RMD News: GMED Stock Rides on NuVasive Synergy Benefits Amid Macro Issues - 11th Jan 2025, 2:24am

annb0t

Top 20
Globus Medical GMED continues to gain from surging demand for its Musculoskeletal Solutions products. However, a challenging macroeconomic scenario continues to plague Globus Medical. The stock carries a Zacks Rank #3 (Hold) currently.

Factors Driving GMED's Shares

Globus Medical is gaining market share in the musculoskeletal solutions space, banking on the strong performance of its implantable devices, biologics, accessories and unique surgical instruments used in an expansive range of spinal...

>>> Read more: GMED Stock Rides on NuVasive Synergy Benefits Amid Macro Issues
 
Top Bottom